Nxera Pharma
4565.T
£3.99
Share price
9.46%
Change (1 day)
-52.68%
Change (1 year)
Categories
EPS for Nxera Pharma (4565.T)
EPS in 2024 (TTM): -£0.64
According to Nxera Pharma's latest financial reports the company's current EPS (TTM) is -£0.62. In 2023 the company made an earnings per share (EPS) of -£0.48 a decrease over its 2022 EPS that were of £0.02782.
EPS history for Nxera Pharma from 2005 to 2024
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2024 (TTM) | -£0.64 | 33.38% |
| 2023 | -£0.48 | -1829.25% |
| 2022 | £0.02782 | -67.15% |
| 2021 | £0.08470 | -40.17% |
| 2020 | £0.14 | 5.97% |
| 2019 | £0.13 | -124.17% |
| 2018 | -£0.55 | -157.64% |
| 2017 | £0.96 | -691.98% |
| 2016 | -£0.16 | -366.52% |
| 2015 | £0.06078 | -74.61% |
| 2014 | £0.24 | 45.12% |
| 2013 | £0.16 | -142.56% |
| 2012 | -£0.39 | 4.42% |
| 2011 | -£0.37 | 18.94% |
| 2010 | -£0.31 | -52.47% |
| 2009 | -£0.66 | -161% |
| 2008 | £1.08 | -205.26% |
| 2007 | -£1.02 | 23.33% |
| 2006 | -£0.83 | 42.13% |
| 2005 | -£0.58 |